Evidence map›Paper›PMID 36706119›Full record

Observational studyPloS one2023

Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: An observational cohort study.

Naomi F Walker, Rachel L Byrne, Ashleigh Howard, Elissavet Nikolaou, Madlen Farrar, Sharon Glynn, Katerina S Cheliotis, Ana I Cubas Atienzar, Kelly Davies, Jesús Reiné and 18 more

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Oral SARS-CoV-2 Infection and Risk for Long Covid.Reviews in medical virology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Naomi F WalkerClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-3345-7694
Rachel L ByrneCentre for Drugs and Diagnostics, Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Ashleigh HowardClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Elissavet NikolaouClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Madlen FarrarClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Sharon GlynnClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Katerina S CheliotisClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-5992-4596
Ana I Cubas AtienzarCentre for Drugs and Diagnostics, Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-9604-124X
Kelly DaviesClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Jesús ReinéClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Zalina Rashid-GardnerNIHR Liverpool and Broadgreen Clinical Research Facility, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Esther L GermanClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Carla SolórzanoClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Tess BlandamerClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-4899-015X
Lisa HitchinsClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Christopher MyerscoughClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Bradford D GessnerPfizer Vaccines, Collegeville, Pennsylvania, United States of America.
Elizabeth BegierPfizer Vaccines, Collegeville, Pennsylvania, United States of America.
Andrea M CollinsClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Mike BeadsworthTropical and Infectious Diseases Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Stacy ToddTropical and Infectious Diseases Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Helen HillClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Catherine F HoulihanDepartment of Clinical Virology, University College London Hospitals, London, United Kingdom.
Eleni NastouliDepartment of Clinical Virology, University College London Hospitals, London, United Kingdom.
Emily R AdamsCentre for Drugs and Diagnostics, Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Elena MitsiClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Daniela M FerreiraClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
SAFER investigators

Funding

Department of HealthMedical Research Council MC_PC_19082Medical Research Council MR/T001127/1
6 · The paper itself

Abstract

backgroundThe SARS-CoV-2 pandemic has caused an unprecedented strain on healthcare systems worldwide, including the United Kingdom National Health Service (NHS). We conducted an observational cohort study of SARS-CoV-2 infection in frontline healthcare workers (HCW) working in an acute NHS Trust during the first wave of the pandemic, to answer emerging questions surrounding SARS-CoV-2 infection, diagnosis, transmission and control.

methodsUsing self-collected weekly saliva and twice weekly combined oropharyngeal/nasopharyngeal (OP/NP) samples, in addition to self-assessed symptom profiles and isolation behaviours, we retrospectively compared SARS-CoV-2 detection by RT-qPCR of saliva and OP/NP samples. We report the association with contemporaneous symptoms and isolation behaviour.

resultsOver a 12-week period from 30th March 2020, 40·0% (n = 34/85, 95% confidence interval 31·3-51·8%) HCW had evidence of SARS-CoV-2 infection by surveillance OP/NP swab and/or saliva sample. Symptoms were reported by 47·1% (n = 40) and self-isolation by 25·9% (n = 22) participants. Only 44.1% (n = 15/34) participants with SARS-CoV-2 infection reported any symptoms within 14 days of a positive result and only 29·4% (n = 10/34) reported self-isolation periods. Overall agreement between paired saliva and OP/NP swabs was 93·4% (n = 211/226 pairs) but rates of positive concordance were low. In paired samples with at least one positive result, 35·0% (n = 7/20) were positive exclusively by OP/NP swab, 40·0% (n = 8/20) exclusively by saliva and in only 25·0% (n = 5/20) were the OP/NP and saliva result both positive.

conclusionsHCW are a potential source of SARS-CoV-2 transmission in hospitals and symptom screening will identify the minority of infections. Without routine asymptomatic SARS-CoV-2 screening, it is likely that HCW with SARS-CoV-2 infection would continue to attend work. Saliva, in addition to OP/NP swab testing, facilitated ascertainment of symptomatic and asymptomatic SARS-CoV-2 infections. Combined saliva and OP/NP swab sampling would improve detection of SARS-CoV-2 for surveillance and is recommended for a high sensitivity strategy.

Indexed as

COVID-19SalivaCohort StudiesHealth PersonnelHumansNasopharynxRetrospective StudiesSARS-CoV-2Specimen HandlingState Medicine

Identifiers

PMID36706119
PMCPMC9882898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.